Le Lézard
Classified in: Health
Subjects: HSP, DEI

Blue Shield of California Promise Health Plan Statement: Department of Health Care Services Decision on Medi-Cal Contract Award is Disservice to Vulnerable Californians


MONTEREY PARK, Calif., Aug. 30, 2022 /PRNewswire/ -- Blue Shield of California Promise Health Plan adamantly disagrees with the Department of Health Care Services' (DHCS) failure to issue a notice of intent to award to Blue Shield Promise a managed care plan contract to serve Medi-Cal beneficiaries in San Diego County and other bid markets.

This decision is not consistent with the stated goals of the procurement and therefore is not in the best interest of Medi-Cal beneficiaries and their communities. Blue Shield Promise is evaluating all avenues to appeal this decision as it continues its commitment as a nonprofit managed care plan to serve its members and provide them with access to quality care.

Blue Shield Promise (formerly Care1st Health Plan) has been serving Medi-Cal beneficiaries in San Diego and Los Angeles counties for more than 25 years, and its parent company, Blue Shield of California has been serving the state's residents for more than 80 years. Together, they are tax-paying, mission-driven nonprofit health plans operating exclusively in California.

About Blue Shield of California Promise Health Plan
Blue Shield of California Promise Health Plan is a managed care organization, wholly owned by Blue Shield of California, offering Medi-Cal and Cal MediConnect. It is led by healthcare professionals with a "members-first" philosophy and committed to building a quality network of providers and partnering with community organizations for more than 400,000 members. For more information about Blue Shield of California Promise Health Plan, please visit www.blueshieldca.com/promise.

For more news about Blue Shield of California, please visit https://news.blueshieldca.com/. Or follow the health plan on LinkedInTwitter, or Facebook.

CONTACT:   

Erika Conner


Blue Shield of California    


510-607-2359


[email protected]  

SOURCE Blue Shield of California Promise Health Plan


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: